[Testing of orally administered spasmolytics demonstrated by the effect of hyoscine-N-butylbromide on gastric motility].
D000328:Adult; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004571:Electrokymography; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000494:pharmacology*; D010919:Placebos; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology*; D013270:Stomach / Q000187:drug effects*
D010919:Placebos; D012601:Scopolamine
Die Testung oral applizierter Spasmolytica am Beispiel der Wirkung von Hyoscin-N-butylbromid auf die Magenmotilität.